Project Grant K23MH133986
- This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will fund a research project titled "AUGMENTING COGNITIVE PROCESSING THERAPY WITH A PEER-LED SUPPORT INTERVENTION TO IMPROVE WELL-BEING: A SUSTAINABLE AND SCALABLE MODEL FOR ENHANCING PTSD RECOVERY IN VULNERABLE POPULATIONS." The $567,000 award to Trustees of Boston University's Medical Campus will support the development and evaluation of a model...
- This Project Grant award, provided by the National Institute of Mental Health (CFDA 93.242 Mental Health Research Grants), supports the development of an adaptive intervention to improve access, engagement, and effectiveness of posttraumatic stress disorder (PTSD) treatment in routine care settings. The $939,784 award to Boston Medical Center Corporation aims to sequence a digital behavioral health intervention and brief trauma- and skills-focused treatments for PTSD. The selected treatments are...
- This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $610,152 to Duke University to study the structural and functional architecture of cortico-cerebellar systems in post-traumatic stress disorder (PTSD). The key objectives are to investigate the influence of PTSD, trauma exposure, and PTSD symptom clusters on the functional connectivity of cerebellar subregions to cortical and subcortical regions,...
- This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $2,326,715 to the Boston VA Research Institute, Inc. (BVARI) to develop and conduct a preliminary evaluation of a self-directed, internet-based Cognitive Processing Therapy (CPT) intervention. The funding period is from September 1, 2024 to August 31, 2028. The key products and services to be delivered under this grant include: Developing the web-based CPT...
- This Project Grant award of $2,384,097, provided by the Defense Health Agency through the Military Medical Research and Development (CFDA 12.420) federal grant program, is funding a hybrid experimental clinical trial to determine the optimal sequencing of interventions to maximize the effectiveness of PTSD treatment. The primary awardee, The University of Texas Health Science Center at San Antonio, will conduct this research with a planned completion date of August 2028. The project involves two...
- This federal Project Grant award, valued at $3,141,404.00 and issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports a randomized controlled trial to evaluate the efficacy of combined cognitive processing therapy and stellate ganglion blocks for the treatment of post-traumatic stress disorder (PTSD). The award was granted to Rush University Medical Center, a prominent academic medical center in Chicago, Illinois, to conduct this...
- This Project Grant award of $180,439 from the National Institute of Mental Health (NIMH), under the CFDA program "Mental Health Research Grants", will support new mentored training in the computational neuroscience of higher-order threat learning and memory in post-traumatic stress disorder (PTSD) for the award recipient as they transition to an independent research faculty role. The objective is to build on the recipient's functional MRI training and incorporate new training in...
- This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $424,175 to Virginia Commonwealth University (VCU) to conduct research aimed at understanding the genomic basis of post-traumatic stress disorder (PTSD). The study will leverage existing large-scale whole exome and whole genome sequencing datasets and biorepositories to identify additional genetic signals for PTSD by integrating rare variants...
- This $769,753 federal Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), aims to leverage large-scale multimodal neuroimaging datasets to identify neural biomarkers and biotypes underlying post-traumatic stress disorder (PTSD), major depressive disorder (MDD), and anxiety disorders (ANXs). The research project, with an award period from Jul 21, 2025 to Apr 30, 2030, will utilize explainable deep learning...
- This $2,763,615 federal Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) supports a randomized controlled trial of brief prolonged exposure therapy for injured individuals admitted to a Level I trauma center. The goal is to evaluate the effectiveness of this approach in preventing post-traumatic stress disorder (PTSD) in this patient population. The 4-year study is being conducted by the Baylor Research Institute, a non-profit...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), is intended to refine and pilot test an adapted version of Cognitive Processing Therapy (CPT) that incorporates elements to address "lived experience stress" in addition to posttraumatic stress disorder (PTSD) symptoms. The total funding amount for this 5-year project is $191,972, with an award date of September 8, 2025. The key objectives are to: 1) refine the adapted CPT therapy through stakeholder engagement and beta testing with 6 impacted individuals (Aim 1); and 2) conduct a pilot randomized controlled trial of the adapted intervention with 52 participants (Aim 2-3). This work aims to demonstrate the feasibility, acceptability, and engagement with the novel intervention targets related to internal stress processes, to ultimately improve treatments for PTSD and co-occurring lived experience stress among populations facing health disparities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $192.0k | 9/8/25 |